Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential of Liquid Biopsy in Papillary Thyroid Carcinoma in Context of miRNA, BRAF and p53 Mutation.

Current drug targets - 1 Jan 2018

Perdas Ewelina, Stawski Robert, Nowak Dariusz, Zubrzycka Maria

Abstract excerpt

BACKGROUND: Liquid biopsy is a minimally invasive detection method for molecular biomarkers such as miRNA and cell free DNA in body fluids. Deregulations of miRNA are involved in papillary thyroid carcinoma (PTC), one the most common endocrine malignancy. The most widespread common mutations detected in papillary thyroid cancers are BRAF mutations. Many studies indicate that the BRAF mutation is related to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell-Free Nucleic Acids
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liquid Biopsy

Share to MicroRNAs

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 29484992
DOI: 10.2174/1389450119666180226124349

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential of Liquid Biopsy in Papillary Thyroid Carcinoma in Context of miRNA, BRAF and p53 Mutation.PMID 29484992Read ↗

MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and TreatmentSemantic proximity Read ↗

Emerging Biomarkers in Thyroid Practice and ResearchSemantic proximity Read ↗

In Search of Easily Accessible and Reliable Malignancy Biomarkers in Liquid Biopsies: The Case of miRNAs in Extracellular Vesicles in the Plasma of Patients with Papillary Thyroid CancerSemantic proximity Read ↗

MiRNAs in Extracellular Vesicles as Biomarkers in Plasma of Papillary Thyroid Cancer Patients: A Proof-of-Concept StudySemantic proximity Read ↗

Differential microRNA expression for diagnosis and prognosis of papillary thyroid cancerSemantic proximity Read ↗

Differential MicroRNA-Signatures in Thyroid Cancer SubtypesSemantic proximity Read ↗

Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.Semantic proximity Read ↗

Molecular Testing Based Assessment of the Potential Aggressiveness of Papillary Thyroid CarcinomaSemantic proximity Read ↗

Prediction of the Aggressive Clinical Course of Papillary Thyroid Carcinoma Based on Fine Needle Aspiration Biopsy Molecular Testing.Semantic proximity Read ↗

The role of microRNAs in thyroid carcinomas.Semantic proximity Read ↗

ROLE OF MOLECULAR MARKERS IN THYROID NODULE MANAGEMENT: THEN AND NOW.Semantic proximity Read ↗

Update on Fundamental Mechanisms of Thyroid Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.